Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease

Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation

(2010) Zhongqi Zhang et al.   PROTEIN SCIENCE

Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells

(2009) Brigitte Rigat et al.   MOLECULAR GENETICS AND METABOLISM

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts

(2009) Caterina Porto et al.   MOLECULAR THERAPY

Gaucher disease: improving management

(2008) Bruno Bembi et al.   ACTA PAEDIATRICA

The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations

(2008) Ozlem Goker-Alpan et al.   ARCHIVES OF NEUROLOGY

Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase

(2008) Jin-Song Shen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Isofagomine Induced Stabilization of Glucocerebrosidase

(2008) Gregory J. Kornhaber et al.   CHEMBIOCHEM

Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry

(2008) Michael B. Tropak et al.   CHEMBIOCHEM

Ambroxol: A CNS Drug?

(2008) Thomas Weiser   CNS Neuroscience & Therapeutics

Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosis

(2008) William Boston-Howes et al.   EXPERIMENTAL NEUROLOGY

Ambroxol in the 21st century: pharmacological and clinical update

(2008) Mario Malerba et al.   Expert Opinion on Drug Metabolism & Toxicology

Treatment perspectives for the lysosomal storage diseases

(2008) Gregory A Grabowski   EXPERT OPINION ON EMERGING DRUGS

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)

(2008) Kathleen S. Hruska et al.   HUMAN MUTATION

Fully Automated Molecular Mechanics Based Induced Fit Protein−Ligand Docking Method

(2008) Jürgen Koska et al.   Journal of Chemical Information and Modeling

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring

(2008) T. M. Cox et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease

(2008) Maria Fuller et al.   MOLECULAR GENETICS AND METABOLISM

Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis

(2008) Douglas R. Martin et al.   MOLECULAR GENETICS AND METABOLISM

Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease

(2008) Naoki Masuda et al.   NEUROBIOLOGY OF DISEASE

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

(2008) Z. Gan-Or et al.   NEUROLOGY